C Liaskos
Overview
Explore the profile of C Liaskos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
161
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kokkinos A, Liaskos C, Alexiadou K, Papassotiriou I, Margeli A, Argyrakopoulou G, et al.
J Endocrinol Invest
. 2020 Jul;
44(3):599-608.
PMID: 32681464
Purpose: Low-grade inflammation in obesity contributes to the development of cardiovascular disease, diabetes mellitus and cancer, and is associated with increased mortality. The purpose of this 1-year prospective observational study...
2.
Liaskos C, Rentouli S, Simopoulou T, Gkoutzourelas A, Norman G, Brotis A, et al.
Br J Dermatol
. 2019 Mar;
181(1):138-146.
PMID: 30875084
Background: Anti-C1q autoantibodies (autoAbs) are associated with systemic lupus erythematosus (SLE), but their presence in other rheumatic diseases has not been adequately investigated. Objectives: We aimed to assess anti-C1q autoAbs...
3.
Kamposioras K, Anthoney A, Fernandez Moro C, Cairns A, Smith A, Liaskos C, et al.
Br J Surg
. 2013 Dec;
101(2):89-99.
PMID: 24375301
Background: The clinicopathological factors that influence survival following pancreatoduodenectomy (PD) for common bile duct (CBD) cancer are not well known. This study aimed to investigate the effect of tumour involvement...
4.
Liaskos C, Bogdanos D, Davies E, Dalekos G
J Clin Pathol
. 2007 Jan;
60(1):107-8.
PMID: 17213359
No abstract available.
5.
Gatselis N, Georgiadou S, Koukoulis G, Tassopoulos N, Zachou K, Liaskos C, et al.
Aliment Pharmacol Ther
. 2006 Nov;
24(11-12):1563-73.
PMID: 17094775
Background: Development of organ- and non-organ-specific autoantibodies has been reported in hepatitis C virus patients treated with interferon-alpha plus/minus ribavirin. Aims: To address whether prevalence and the titre of gastric...
6.
Rigopoulou E, Davies E, Pares A, Zachou K, Liaskos C, Bogdanos D, et al.
Gut
. 2005 Mar;
54(4):528-32.
PMID: 15753539
Background: Antinuclear antibodies (ANA) giving a rim-like/membranous (RL/M) or a multiple nuclear dot (MND) pattern are highly specific for primary biliary cirrhosis (PBC). Aim and Subjects: To assess the prevalence...
7.
Georgiadou S, Zachou K, Rigopoulou E, Liaskos C, Mina P, Gerovasilis F, et al.
J Viral Hepat
. 2004 Jul;
11(4):358-65.
PMID: 15230859
Occult hepatitis B virus (HBV) infection has been reported in patients with chronic hepatitis C who are negative for HBV surface antigen (HBsAg). However, the significance of 'silent' HBV in...
8.
Zachou K, Liaskos C, Christodoulou D, Kardasi M, Papadamou G, Gatselis N, et al.
Eur J Clin Invest
. 2003 Feb;
33(2):161-8.
PMID: 12588291
Background: Although controversial, some authorities have implicated hepatitis C virus (HCV) as a cause of anti-phospholipid syndrome (APLS). Anti-cardiolipin antibodies (anti-CLAbs) in APLS are cofactor-dependent ('pathogenic' antibodies). We conducted a...
9.
Dalekos G, Zachou K, Liaskos C, Gatselis N
Eur J Intern Med
. 2002 Jul;
13(5):293-303.
PMID: 12144908
Autoimmune hepatitis (AIH) is a disease of unknown aetiology characterised by hypergammaglobulinaemia, non-organ and liver-related autoantibodies, association with HLA-DR3 or DR4 and a favourable response to immunosuppression. The current classification...
10.
Dalekos G, Zachou K, Liaskos C
Curr Rheumatol Rep
. 2001 Jul;
3(4):277-85.
PMID: 11470045
Infectious agents have been implicated in the induction of antiphospholipid (aPL) antibodies and the development of the antiphospholipid syndrome (APS). This review focuses on the types of aPL antibodies detected...